makers of semaglutide FDA Warns on Certain Forms Compounded Wegovy Maker Launches Lower-Cost Subscription

Serious adverse events were uncommon in both groups

Discussion The global diabetes epidemic, affecting approximately 828 million adults in 2022 32 , has driven widespread adoption of GLP-1 RAs due to their dual glycemic and weight management benefits 33,34,35

Official Details: Medication: Tirzepatide (identical to Mounjaro) Manufacturer: Eli Lilly FDA Approval: November 2023 Approved For: Chronic weight management in adults with obesity or overweight with weight-related conditions Dosing: Once-weekly injection Available Doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg List Price: $1,069 per month (same as Mounjaro) How Zepbound Differs from Mounjaro: The medications are completely identical

Related Mateusz Maszczynski honed his skills as an international flight attendant at the most prominent airline in the Middle East and has been flying ever since

That makes effective contraception while youre on GLP-1s more important, not less

Oral Wegovy (25mg daily tablet) was FDA-approved in December 2025 and launched January 2026